Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a collaboration with Galapagos.
Source link
About The Author
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets